title: The autocrine motility factor receptor is overexpressed on the surface of B cells in Binet C chronic lymphocytic leukemia.
abstract: Chronic lymphocytic leukemia (CLL) is a heterogeneous disease with a clinical spectrum reaching from discrete lymphocytosis to extensive enlargement of lymph nodes, spleen and liver, and bone marrow failure. The aim of this study was to identify genes that differentiate between patients with disease stage A vs. C according to Binet in order to better understand the disease. To achieve this, we performed DNA microarray analysis on B cells from CLL patients with stage A and C according to Binet and matched controls. Between CLL patients and controls, there were 1,528 differentially expressed genes and 360 genes were differentially expressed between Binet A and C patients. Due to the sheer number of regulated genes, we focused on the autocrine motility factor receptor (AMFR). AMFR has not previously been investigated in hematological disorders, but high expression of AMFR correlates with a more advanced stage and invasive potential in several human tumors. AMFR mRNA expression was higher in Binet A compared with Binet C patients (P=0.0053) and healthy controls (P=0.0051). Total AMFR protein was higher in Binet A patients compared to Binet C as analyzed by intracellular flow cytometry. However, AMFR exist both in the ER involved in protein degradation and on the cell surface involved in metastasis and cell motility. Cell surface AMFR was increased in Binet C compared with Binet A+B (P=0.016). In conclusion, the mRNA levels reflect the total amount of AMFR, whereas cell surface expression is associated with progression in CLL.
authors.affiliation: Department of Internal Medicine, Section of Hematology and Coagulation, Sahlgrenska University Hospital, University of Gothenburg, 413 45, Gothenburg, Sweden. sofia.grund@medic.gu.se
authors.forename: Sofia
authors.initials: S
authors.lastname: Grund
authors.forename: Bob
authors.initials: B
authors.lastname: Olsson
authors.forename: Margareta
authors.initials: M
authors.lastname: Jernås
authors.forename: Stefan
authors.initials: S
authors.lastname: Jacobsson
authors.forename: Birgitta
authors.initials: B
authors.lastname: Swolin
authors.forename: Ivan R
authors.initials: IR
authors.lastname: Nabi
authors.forename: Lena
authors.initials: L
authors.lastname: Carlsson
authors.forename: Hans
authors.initials: H
authors.lastname: Wadenvik
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001402:B-Lymphocytes / Q000378:metabolism* / Q000473:pathology; D002469:Cell Separation; D018450:Disease Progression; D005260:Female; D005434:Flow Cytometry; D020869:Gene Expression Profiling; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000235:genetics* / Q000378:metabolism* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D020411:Oligonucleotide Array Sequence Analysis; D012333:RNA, Messenger / Q000032:analysis; D060285:Receptors, Autocrine Motility Factor / Q000096:biosynthesis* / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D015854:Up-Regulation
chemical_list: D012333:RNA, Messenger; C555000:AMFR protein, human; D060285:Receptors, Autocrine Motility Factor